57

The Geron Corporation (NASDAQ:GERN) is going up by 0.35% in today’s trading session. A news came out on 09/30/19 stating that Geron Announces Fast Track Designation Granted to Imetelstat for Relapsed/Refractory Myelofibrosis by WSJ. The lowest point that the shares touched during the trading session was $1.37, while the peak of the day was recorded at a share price of $1.44. GERN finished the previous session at $1.41 according to the data provided by Barchart, while the trading volume was observed to be $536553.

In the 100 days of trading, GERN managed to top a 1.39% Moving average. Additionally, Geron Corporation shares have achieved a 52-week range between 0.95 and 2.14 alongside 100 days raw stochastic set at 61.40%.

The number of shares outstanding, according to the fundamentals of the company, is set at 192.38M, equal to the value of $271.26M in market capitalization. In the last 30 days, Geron Corporation shares went down by -12.80%, adding 1.64 to growth in value, on top of a +10.85% boost since 09/09/19.

Geron Corporation (NASDAQ:GERN) Analyst’s Estimates

Geron Corporation (GERN) could record at least -$0.15 per share in quarterly earnings in the upcoming report, a number that would actually represent a decrease of -0.37 YOY.

According to the average analyst rating, Geron Corporation would be rated as Buy. Out of 5 different analysts monitoring GERN stock, 5 analysts rate the stock as a BUY, 0 suggest to give the rating of HOLD, 0 indicate that GERN is an OVERWEIGHT, 0 rated the stock as a SELL, and 0 analyst believes that the stock should be rated as UNDERWEIGHT.

On September 03, 2019, the stock earned a Initiated rating due to a new analyst call from H.C. Wainwright, while analysts from Cantor Fitzgerald believe that the stock is set at Overweight, as concluded on August 15, 2019. Needham, is still rather wary about the stock, deciding to keep the rating at Buy as confirmed through a call on April 09, 2019.

Regardless of the rating, B. Riley FBR did increase their price from $1.50 to $3.25 as they are considering target share price analysis. B. Riley FBR, on the other hand, provided a rather enthusiastic opinion on the rating, concluded in an analyst call on October 02, 2018, giving the stock a Neutral from the Buy rating.

GERN Key Ratios To Watch:

Beta value of the stock is recorded at 2.42. Additionally, Geron Corporation is recording price volatility of 4.86% for the period of the last seven days and 5.54% in the last 30 days.

Geron Corporation (NASDAQ:GERN) Technical Outlook

For the period of the last 50 days, Geron Corporation had its Raw Stochastic average set at 60.38% for the latest technical analysis. In comparison to the period of the last 20 days, the present Raw Stochastic average for the last 50 days poses as improvement, set at 40.00%. Stochastic %K for Geron Corporation, with the last 20 days included, was set at 38.10%, having Stochastic %D topping 39.68%. Based on the previous performance of the company for the mentioned period, there are more than several recorded moving trends. When it comes to the period of the last 12 months, accounting the time for year-to-date, price performance appears to be encouraging for Geron Corporation stocks with recording 41.00% in metrics.

Geron Corporation Insider Watch:

Similarly, 34.24% of the company’s float is held by institutions – and there are 179 institutions in total holding shares of this company. The top three institutional holders of GERN stocks are: FMR, LLC with ownership of $21.91 million, which is approximately 15536850 of the company’s shares; Blackrock Inc., holding 14649266 shares of the stock with an approximate value of $20.66 million; and Vanguard Group, Inc. (The), currently with more than 9644900 shares of the company valued at $13.6 million. Positions in Geron Corporation stocks held by institutional investors has been changing actively in the past six months, a period during which there were 2 insider purchases amounting to 10501 shares. Similarly, there were 1 sale transactions amounting to 120635 shares, with the net shares purchased during the last six months reaching -110,134.